Search research articles
Contact Us
Filters
Showing results (151-160 of 272) with videos related to
Page
of 28
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)
M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
Anticancer Research
|
May 4, 2005
Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
Cecilia Nisticò, Andrea De Matteis, Emanuela Rossi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 23, 2022
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
Clorinda Schettino, Lucia Musacchio, Michele Bartoletti, et al.
JCO Oncology Practice
|
January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System
Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction
Giuseppe Palmieri, Paolo A Ascierto, Francesco Perrone, et al.
JAMA Network Open
|
February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors
Daniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
BMC Cancer
|
March 26, 2005
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
Ermelinda De Maio, Adriano Gravina, Carmen Pacilio, et al.
Critical Reviews in Oncology/Hematology
|
March 6, 2021
Second medical opinion in oncological setting
Marco Maruzzo, Nicla La Verde, Antonio Russo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2006
Identification of cripto-1 as a novel serologic marker for breast and colon cancer
Caterina Bianco, Luigi Strizzi, Mario Mancino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
Antonio Rossi, Massimo Di Maio, Paolo Chiodini, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 272) with videos related to
Sort By:
Page
of 28
Lung Cancer (Amsterdam, Netherlands)
|
August 22, 2013
Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)
M Neil Reaume, Natasha B Leighl, Nicole Mittmann, et al.
Anticancer Research
|
May 4, 2005
Primary chemotherapy with epirubicin and vinorelbine in women with locally advanced breast cancer
Cecilia Nisticò, Andrea De Matteis, Emanuela Rossi, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 23, 2022
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups
Clorinda Schettino, Lucia Musacchio, Michele Bartoletti, et al.
JCO Oncology Practice
|
January 11, 2024
Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System
Francesco Sparano, Johannes M Giesinger, Gianluca Gaidano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction
Giuseppe Palmieri, Paolo A Ascierto, Francesco Perrone, et al.
JAMA Network Open
|
February 23, 2023
Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors
Daniel A Goldstein, Gary M Ginsberg, Dorit Hofnung-Gabbay, et al.
BMC Cancer
|
March 26, 2005
Compliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experience
Ermelinda De Maio, Adriano Gravina, Carmen Pacilio, et al.
Critical Reviews in Oncology/Hematology
|
March 6, 2021
Second medical opinion in oncological setting
Marco Maruzzo, Nicla La Verde, Antonio Russo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2006
Identification of cripto-1 as a novel serologic marker for breast and colon cancer
Caterina Bianco, Luigi Strizzi, Mario Mancino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 5, 2012
Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
Antonio Rossi, Massimo Di Maio, Paolo Chiodini, et al.
Page
of 28